GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 239 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2019. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $91,000 | +127.5% | 1,145 | +36.6% | 0.00% | – |
| Q3 2019 | $40,000 | -93.3% | 838 | -92.7% | 0.00% | -100.0% |
| Q2 2019 | $600,000 | +1295.3% | 11,404 | +1307.9% | 0.01% | – |
| Q1 2019 | $43,000 | +53.6% | 810 | +15.7% | 0.00% | – |
| Q4 2018 | $28,000 | -22.2% | 700 | -26.1% | 0.00% | – |
| Q3 2018 | $36,000 | -47.1% | 947 | -36.9% | 0.00% | -100.0% |
| Q2 2018 | $68,000 | -34.6% | 1,500 | -30.4% | 0.00% | 0.0% |
| Q1 2018 | $104,000 | +65.1% | 2,155 | +34.7% | 0.00% | 0.0% |
| Q4 2017 | $63,000 | +16.7% | 1,600 | -8.6% | 0.00% | 0.0% |
| Q3 2017 | $54,000 | +5300.0% | 1,750 | +6900.0% | 0.00% | – |
| Q1 2017 | $1,000 | – | 25 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 595,473 | $25,790,000 | 4.19% |
| Grace Capital | 131,549 | $5,697,000 | 3.60% |
| Fernwood Investment Management, LLC | 201,657 | $8,734,000 | 3.44% |
| Fairmount Funds Management LLC | 215,000 | $9,312,000 | 3.33% |
| Arctis Global LLC | 293,700 | $12,720,000 | 2.74% |
| Perceptive Advisors | 5,674,711 | $245,771,000 | 2.64% |
| ArchPoint Investors | 217,510 | $9,420,000 | 2.61% |
| Alerce Investment Management, L.P. | 126,270 | $5,469,000 | 2.15% |
| Profit Investment Management, LLC | 42,196 | $1,826,000 | 1.17% |
| Affinity Asset Advisors, LLC | 50,000 | $2,166,000 | 1.15% |